Clinical trials
Completed Phase 2 Hyperparathyroidism, Secondary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Abbott | 3 |
| Deltanoid Pharmaceuticals | 2 |
| KAI Pharmaceuticals | 2 |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2 |
| Astellas Pharma Inc | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| OPKO IP Holdings II, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 20 |
| Kidney Failure, Chronic | 4 |
| Renal Insufficiency, Chronic | 4 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 2 |
| Hyperparathyroidism | 1 |
| Kidney Diseases | 1 |
| Parathyroid Diseases | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.